BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16080969)

  • 1. Insulin resistance as a predictor for restenosis after coronary stenting.
    Nishio K; Fukui T; Tsunoda F; Kawamura K; Itoh S; Konno N; Ozawa K; Katagiri T
    Int J Cardiol; 2005 Aug; 103(2):128-34. PubMed ID: 16080969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients.
    Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Imai R; Okino K; Takahashi H; Ono T
    Nephron Clin Pract; 2008; 109(1):c9-17. PubMed ID: 18483462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remnant-like lipoprotein particle level and insulin resistance are associated with in-stent restenosis in patients with stable angina.
    Kato T; Inoue T; Inagaki H; Hashimoto S; Hikichi Y; Tanaka A; Isobe M; Node K
    Coron Artery Dis; 2007 Jun; 18(4):319-22. PubMed ID: 17496497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
    Hoye A; Iakovou I; Ge L; van Mieghem CA; Ong AT; Cosgrave J; Sangiorgi GM; Airoldi F; Montorfano M; Michev I; Chieffo A; Carlino M; Corvaja N; Aoki J; Rodriguez Granillo GA; Valgimigli M; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW; Colombo A
    J Am Coll Cardiol; 2006 May; 47(10):1949-58. PubMed ID: 16697310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
    Hong SJ; Kim MH; Ahn TH; Ahn YK; Bae JH; Shim WJ; Ro YM; Lim DS
    Heart; 2006 Aug; 92(8):1119-24. PubMed ID: 16449516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.
    Schober A; Hoffmann R; Oprée N; Knarren S; Iofina E; Hutschenreuter G; Hanrath P; Weber C
    Am J Cardiol; 2005 Oct; 96(8):1116-22. PubMed ID: 16214449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina.
    Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Aquilina M; Corlianò L; Saia F; Taglieri N; Sbarzaglia P; Bacchi Reggiani ML; Branzi A
    Ital Heart J; 2004 Mar; 5(3):189-96. PubMed ID: 15119501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis.
    Feola M; Ribichini F; Ferrero V; Procopio M; Magro G; Vado A; Borretta G; Boccuzzi G; Vassanelli C; Uslenghi E
    Am J Cardiol; 2004 Sep; 94(6):777-80. PubMed ID: 15374787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multivariate analysis of clinical factors in restenosis after coronary interventional treatment].
    Wen S; Mao J; Guo L
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):197-9. PubMed ID: 11601040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.